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Polysome arrest restricts miRNA turnover 
by preventing exosomal export of miRNA 
in growth-retarded mammalian cells
Souvik Ghosh, Mainak Bose, Anirban Ray, and Suvendra N. Bhattacharyya
RNA Biology Research Laboratory, Molecular and Human Genetics Division, CSIR-Indian Institute of Chemical Biology, 
Kolkata 700032, India
ABSTRACT MicroRNAs (miRNAs) are tiny posttranscriptional regulators of gene expression 
in metazoan cells, where activity and abundance of miRNAs are tightly controlled. Regulated 
turnover of these regulatory RNAs is important to optimize cellular response to external 
stimuli. We report that the stability of mature miRNAs increases inversely with cell prolifera-
tion, and the increased number of microribonucleoproteins (miRNPs) in growth-restricted 
mammalian cells are in turn associated with polysomes. This heightened association of miRNA 
with polysomes also elicits reduced degradation of target mRNAs and impaired extracellular 
export of miRNA via exosomes. Overall polysome sequestration contributes to an increase of 
cellular miRNA levels but without an increase in miRNA activity. Therefore miRNA activity and 
turnover can be controlled by subcellular distribution of miRNPs that may get differentially 
regulated as a function of cell growth in mammalian cells.
INTRODUCTION
MicroRNAs (miRNAs) are widely considered to be a key component 
of the gene regulatory circuit in metazoan cells. Essentially, miRNAs 
are 20- to 22-nucleotide (nt) noncoding RNAs that are reported to 
regulate a diverse array of genes, and perturbations of their levels 
and activities underlie several human diseases, including cancers (Lu 
et al., 2005; Bartel, 2009; Iorio and Croce, 2012; Mendell and Olson, 
2012).
One of the strands of the mature miRNA gets incorporated into 
a multicomponent ribonucleoprotein (RNP) complex referred to 
commonly as miRNA-mediated silencing complex (miRISC) or 
microribonucleoproteins (miRNPs) and induces repression of the 
target mRNA by inhibiting the translation and/or affecting its sta-
bility (Filipowicz et al., 2008; Fabian et al., 2010; Huntzinger and 
Izaurralde, 2011). Argonaute (AGO) proteins form the essential 
component of a “minimal” miRNP that interacts with the GW182 
family of proteins to induce clearance of miRNA-targeted mRNAs 
by promoting target mRNA deadenylation and degradation. In 
mammalian cells, miRNA-repressed mRNAs and miRNPs are re-
versibly targeted to P-bodies, the specialized cytoplasmic struc-
tures for storage or degradation of miRNA-repressed mRNAs in 
animal cells (Liu et al., 2005; Pillai et al., 2005).
In mammalian cells, of the four isoforms of Argonaute proteins, 
AGO2 has RNA endonuclease activity and is involved in cleavage of 
the target with perfect complementarity to the bound miRNA. In 
addition, it is also involved in the deadenylation and repression of 
translated messages bearing imperfect complementarity in their 3′ 
untranslated region (UTR; Liu et al., 2004; Rivas et al., 2005). A large 
fraction of cellular AGO2 is associated with the endoplasmic reticu-
lum (ER) and Golgi membrane in animal cells (Cikaluk et al., 1999). 
Biochemical fractionation studies have confirmed the presence of 
miRNA and repressed messages with the detergent-insoluble, ER-
enriched membrane fraction (Pillai et al., 2005). ER is also shown to 
be the site where the nucleation of small interfering RNA (siRNA) 
into functional RISC complex occurs (Stalder et al., 2013). The multi-
vesicular body (MVB) is the other subcellular compartment that has 
recently received attention for its role in miRNA-mediated repres-
sion in animal cells and has been found to be important in restricting 
miRNP recycling (Gibbings et al., 2009; Lee et al., 2009). MVBs 
can potentially merge with cell membranes to form exosomes 
Monitoring Editor
Karsten Weis
ETH Zurich
Received: Nov 10, 2014
Revised: Dec 18, 2014
Accepted: Jan 12, 2015
This article was published online ahead of print in MBoC in Press (http://www 
.molbiolcell.org/cgi/doi/10.1091/mbc.E14-11-1521) on January 21, 2015.
The authors declare no conflict of interest.
Address correspondence to: Suvendra N. Bhattacharyya (sb@csiriicb.in).
© 2015 Ghosh et al. This article is distributed by The American Society for Cell 
Biology under license from the author(s). Two months after publication it is avail-
able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported 
Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).
“ASCB®,” “The American Society for Cell Biology®,” and “Molecular Biology of 
the Cell®” are registered trademarks of The American Society for Cell Biology.
Abbreviations used: ER, endoplasmic reticulum; HDC, high-density culture; LDC, 
low-density culture; MVB, multivesicular body.
 http://www.molbiolcell.org/content/suppl/2015/01/18/mbc.E14-11-1521v1.DC1
Supplemental Material can be found at: 
Volume 26 March 15, 2015 Polysome association inactivates miRNAs | 1073 
cells from HDC and LDC was used to avoid any variance during RNA 
extraction, and miRNA content was normalized against U6snRNA. 
miRNA levels in HDC and LDC cells were also compared and nor-
malized against the cellular DNA content; they were found to be 
comparable between HDC and LDC states (Supplemental Figure 
S1A). miR-122 is a hepatocyte- specific miRNA that is not expressed 
in HeLa or MDA-MB-231 cells. The pre-miR-122 can be expressed 
exogenously from a plasmid under a constitutive U6 promoter driv-
ing pre-miR-122 expression. In mammalian cells, Drosha processes 
pri-miRNAs to generate pre-miRs. Therefore, mature miR-122 levels 
in HeLa and MDA-MB-231 cells expressing pre-miR-122 directly as 
a processed transcript could not be influenced by a change in 
Drosha activity. Of interest, as observed for other miRNAs, a compa-
rable increase in mature miR-122 production in pre-miR-122–ex-
pressing HDC HeLa and MDA-MB-231cells was detected, which 
argues in favor of a Drosha-independent up-regulation of mature 
miR-122 level in these cells (Figure 1B). Consistent with this observa-
tion, the Drosha levels were found to be similar between HDC and 
LDC cells (Supplemental Figure S1B). In addition, only a fractional 
change in levels of miRNA precursors pri- and pre-let-7a, insufficient 
to explain the increase in mature let-7a content in HDC HeLa and 
MDAM-MB-231 cells, was noted with change in cell confluency 
(Figure 1, C and D).
In HDC cells, there was also no gross change in AGO protein 
expression, whereas AGO2-associated miRNA levels increased 
(Figure 1E and Supplemental Figure S1, B and C). Moreover, the 
difference in amount of de novo synthesized miRNAs that get 
loaded to AGO2 in LDC and HDC cells expressing inducible pre-
miR-122 was nonsignificant during the initial induction hours and 
therefore could not significantly account for the difference in mature 
miRNA content or its AGO2 association between LDC and HDC 
cells (Figure 1, B and F). Dicer1 immunoprecipitated from HDC or 
LDC cells also did not show any difference in pre-miR processing 
activity (Supplemental Figure S1D), and HDC and LDC cells showed 
a very similar level of Dicer1 expression (Supplemental Figure S1B). 
Therefore higher Dicer1 activity also could not be entirely respon-
sible for the increased mature miRNAs found in HDC cells.
These results suggested that the enhanced miRNA levels in HDC 
cells are primarily due to changes in postmaturation stages of miR-
NAs in HDC. To verify this hypothesis, we measured the level of an 
exogenously administered siRNA in LDC and HDC cells and found 
it to be higher in HDC cells (Supplemental Figure S2, A–C). Note 
that siRNAs do not need any processing or maturation by Drosha, 
and their level in Dicer1-compromised HDC cells was similar to con-
trol HDC cells (Supplemental Figure S2B). Thus the higher level of 
miRNAs could not be solely due to either higher Drosha/Dicer1 ac-
tivity or miRNA loading to AGO proteins in HDC cells.
We wanted to verify the stability of mature miRNAs in LDC 
and HDC mammalian cells. Application of the RNA polymerase 
II inhibitor α-amanitin (α-Am) was used to inhibit de novo pro-
duction of let-7a transcripts (observed with reduction in pre-let-
7a level with α-Am treatment; unpublished data). After 10 h of 
α-Am treatment, the residual amount of let-7a was higher in 
HDC than in LDC HeLa cells (Figure 1G). Increased cell density 
also reduced the depletion of let-7a in the presence of α-Am in 
human MDA-MB-231 breast cancer cells (Figure 1H). Similarly, 
quantitative estimation revealed a reduced half-life of ectopi-
cally expressed, liver- specific miR-122 in the presence of α-Am 
in LDC HeLa cells (Figure 1I). Similar to miRNAs, the half-life of a 
siRNA was also observed to be higher in HDC cells (Supplemen-
tal Figure S2C). The foregoing experiments show that the in-
creased levels of miRNAs were primarily due to the increased 
(Keller et al., 2006), which are small, 30- to 100-nm vesicles consid-
ered as means of intercellular communication and are secreted by 
animal cells to the extracellular space (Simons and Raposo, 2009). 
Several miRNAs and their associated proteins, such as AGO2 and 
GW182, are present in exosomes (Valadi et al., 2007). However, the 
significance of miRNA export via exosomes as a regulator of cellular 
miRNA activity is underexplored.
In contrast to the substantial amount of research on miRNA bio-
genesis, little work has been carried out on miRNA localization and 
turnover in mammalian cells. It has been observed that the half-lives 
of miRNAs in animal cells and tissues such as heart or liver are sev-
eral hours or even days (van Rooij et al., 2007; Gatfield et al., 2009; 
Krol et al., 2010a). However, such a slow turnover rate is not likely to 
be the common feature of all miRNAs, as they play critical roles in 
developmental transitions that demand rapid turnover. Other inves-
tigations have indicated that both the cellular levels and activities of 
miRNAs are subjected to tight regulation. Tissue-specific expression 
and activity of hundreds of miRNAs are controlled at different levels 
to fine tune gene expression in metazoans (Bushati and Cohen, 
2007), where Drosha-DGCR8 and Dicer-TRBP complexes act in tan-
dem to generate mature 22-nt-long miRNAs from their precursors 
(Krol et al., 2010b). Expression and activity of miRNAs are also sensi-
tive to cellular context (Hatfield et al., 2005; Sood et al., 2006), and 
cell–cell contact is reported to increase primary (pri-) miRNA pro-
cessing in a majority of human cell lines tested (Hwang et al., 2009). 
Prototypes of such positive and negative feedback mechanisms to 
control miRNAs remain limited to specific miRNAs and are largely 
operative at miRNA synthesis and/or maturation steps (Krol et al., 
2010a).
In this article, we document a global increase in miRNA stability 
in human cells grown to confluent conditions. Processed siRNA 
molecules that do not require an in vivo Dicer processing step were 
also found to be increasingly stable in growth-retarded human cells. 
Increased miRNAs that were found to be largely engaged with poly-
somal fractions were surprisingly inept at inducing degradation of 
target mRNAs. This is coupled with impaired export of miRNA via 
exosomes. On the contrary, in proliferating cells, miRNPs actively 
engaged in repression are predominantly nonpolysomal and can be 
efficiently exported via exosomes to the extracellular space. There-
fore altered subcellular compartmentalization of miRNPs can result 
in a difference in activity and fate of miRNAs in mammalian cells.
RESULTS
Increased stability of mature miRNAs in human cells grown 
to high cell density in monolayer culture
Increase in miRNA level with cellular confluency has been reported 
for the majority of miRNAs and was shown to be attributed to en-
hanced pri-miRNA processing by Drosha and higher loading of ma-
ture miRNAs to AGO2 in cells from confluent cultures (Hwang et al., 
2009). To assess how cellular growth conditions may affect miRNA 
stability, we measured mature miRNA levels in human cells grown to 
different densities in monolayer culture. Toward that end, we incu-
bated equal numbers of cells in culture plates of different sizes to 
achieve a gradient of cell density in culture. With changing cell den-
sities from 25 to 100%, an increase in mature miR-122 level was 
observed in human Huh7 hepatoma cells. Similarly, mature let-7a 
level also increased with increasing cell density in the human cervi-
cal carcinoma cell line HeLa (Figure 1A). Similar increase of three 
independent miRNAs was detected in both HeLa and MDA-MB-231 
human breast cancer cells grown to high-density culture (HDC; 90–
100% cell density) in comparison to their levels in cells in low-density 
culture (LDC; 20–30% cell density; Figure 1B). Equal numbers of 
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half-life of the mature miRNAs in HDC 
cells.
Reduced miRISC activity in HDC cells
To ascertain whether the elevated miRNAs 
in HDC cells were part of “active” miRNPs, 
we expressed a Renilla reporter containing a 
perfect miR-122 binding site (Figure 2A, left) 
in HeLa cells coexpressing miR-122. Of in-
terest, the in vivo activity of miR-122 RISC 
was almost equal between HDC and LDC 
cells under identical experimental parame-
ters and was inconsistent with the higher 
miRNP present in HDC cells (Figure 2A, 
right, and Figure 1, B and E).
To ascertain whether the reduced in 
vivo activity is due to modification of 
miRNPs in HDC cells that might have ren-
dered them nonfunctional, we purified the 
RISC complex from LDC and HDC cells. 
Consistent with the higher level of miR-122 
in HDC cells, purified miRNP-122 from 
HDC HeLa cells showed 1.8-times-higher 
target cleavage activity in vitro for the same 
amount of AGO2 protein (Figure 2B). Re-
duced in vivo silencing by miRNPs in HDC 
cells could be due to the presence of limit-
ing substrate RNA, which might lead to 
saturation of miRISC activity in LDC and 
HDC cells, or, alternatively, inefficiency of 
FIGURE 1: Effect of cell density on cellular levels, stability, and AGO2 association of miRNAs in 
monolayer culture of mammalian cells. (A) Northern blot detection of miR-122 and let-7a in 
Huh 7 (left) and HeLa cells (right) grown to increasing cell densities (25–100%). U6 RNA serves as 
a loading control. (B) Real-time-based quantitative estimation of the increase of miRNA let-7a, 
miR-16, and exogenously introduced miR-122 levels in HeLa and MDA-MB-231 cells grown in 
high-density (HDC) vs. low-density (LDC) cells. For comparison, individual miRNA levels in LDC 
conditions were taken as the unit. miRNA levels were normalized to U6 RNA levels for 
comparison. (C) Levels of pre-let-7a (top) detected with a pre-let-7a specific probe in HeLa cells 
vs. changing cell density. Membrane was also probed against the mature let-7a to detect both 
pre (denoted by an asterisk) and mature forms of this miRNA (bottom). U6 RNA serves as a 
loading control. (D) Relative change in the levels of pre-let-7a and pri-let-7a RNA in HDC HeLa 
and MDA-MB-231 cells estimated by real-time PCR. Levels of respective RNAs in LDC conditions 
were considered as the unit. (E) Quantitative estimation of associated miRNA in AGO2 
immunoprecipitated materials from HeLa and MDA-MB-231 cells grown to low and high density. 
Top, relative increase of each miRNA in HDC conditions, considering LDC levels as the unit. 
Bottom, Western blot of HA-AGO2 immunoprecipitated using anti-HA antibody from HDC and 
LDC HeLa and MDAM-MB-231 cells expressing FH-AGO2. The heavy-chain band of the 
antibody used for precipitation is represented by a star. (F) Left, detection of FH-AGO2 in 
HA-immunoprecipitated materials from HDC and LDC HeLa cells expressing miR-122 from a 
Tet-ON inducible promoter and FH-AGO2. 
Right, real-time-based quantification of 
miR-122 in FH-AGO2 immunoprecipitated 
(IPed) materials after 4 h of induction with 
doxycycline (DOX). miR-122 levels in LDC 
condition was taken as the unit. (G) Half-life 
of let-7a in HeLa cells grown to low (LDC) or 
high (HDC) densities. Cells were treated for 
10 h with α-Am before total RNA isolation 
and Northern blotting for let-7a. (H) let-7a 
detection in total RNA from LDC and HDC 
MDA-MB-231 cells subjected to α-Am 
treatment for 0, 5, or 10 h for let-7a. 
(I) Stability of exogenously expressed 
miR-122 in LDC and HDC HeLa cells. Cells 
expressing pre-miR-122 from a U6 promoter 
were grown to either HDC or LDC before 
α-Am was applied, and levels of mature 
miR-122 after 5 and 10 h of treatment were 
determined by real-time-based quantification 
and plotted. Initial level was considered as 
the unit in each case (left). The initial levels of 
miR-122 in pre-miR-122–expressing HeLa 
cells before addition of α-Am are plotted 
for comparison (right). ns, nonsignificant, 
*p < 0.05, **p < 0.01, ***p < 0.0001. The 
p values were determined by paired t test. 
All experiments were performed a minimum 
of three times. For densitometric 
quantification, the relative amounts of 
miRNAs were measured against the U6 RNA, 
which also served as loading control.
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component of the miRNA-mediated repression pathway, was con-
siderably nonpolysomal in both HDC and LDC cells (Figure 3A). 
Polysome association of AGO2 in HDC cells was confirmed by treat-
ment of the cell extract with puromycin to disrupt the elongating 
polysomes and associated AGO2 in HDC cell extract before it was 
analyzed on a sucrose density gradient (Supplemental Figure S3C). 
Polysome association of AGO2 was also found to be RNA depen-
dent and sensitive to treatment with micrococcal nuclease (Supple-
mental Figure S3D). Therefore, in HDC cells, miRNPs remain associ-
ated with their target mRNA and are stabilized with polysomes.
Increase in cell density was marked by lower expression and re-
duced nuclear localization of proliferating cell nuclear antigen in 
mammalian cells (Supplemental Figure S4, A–C). Increased cellular 
density was also associated with a majority of the cells arrested in sub-
G0/G1 phase of the cell cycle (Supplemental Figure S4D). In mam-
malian tissue such as liver, a majority of the cells are nonproliferative. 
Polysome profile analysis of mouse liver lysate confirmed polysome 
association of both AGO2 and miR-122 similar to what was docu-
mented in HDC cells, which are also nonproliferative (Supplemental 
Figure S3E). Therefore, in nonproliferative mammalian cells, miRNAs 
and AGO2 are primarily associated with polysomes.
To determine whether the polysome-associated AGO2 in HDC 
cells was miRNA bound, we immunoprecipitated AGO2 extracted 
from polysomal fractions of HDC cells, which showed higher RISC 
cleavage activity than that isolated from nonpolysomal fraction. This 
indicated that miRNA-loaded AGO2 associated with polysomes in 
HDC cells (Figure 3B, right). This also rules out the existence of any 
specific modification of miRISC that could inhibit RISC activity of 
polysomal miRNPs in HDC cells. To reconcile this with the polysome 
association of miRNPs, we sought to investigate the cause and ef-
fect of this sequestration. Polysomes isolated from HDC HeLa cells 
showed twofold to threefold higher miRNA level than LDC poly-
somes, reconfirming that the excess miRNA in HDC cells is primarily 
polysomal (Figure 3C). This is also consistent with the increased tar-
get RNA association with polysomes in HDC cells evident from 
quantification of let-7a reporter mRNA RL-3xbulge-let-7a found 
with individual fractions of a sucrose density gradient (Figure 3D). 
However, polysome-associated AGO2 isolated from HDC cells, al-
though enriched with miRNAs, showed relatively less RISC activity in 
vitro for the same amount of miRNA (Figure 4, A and B). From these 
data, we speculated that a fraction of AGO2- loaded miRNA that is 
associated with polysomes is ineffective for target cleavage in HDC 
cells. Is the activity of miRNPs inversely related to its polysome as-
sociation? Boosting translation of isolated polysome-associated 
mRNA in vitro by incubating HDC polysomes with rabbit reticulo-
cyte lysate released miRNP from polysomes and resulted in in-
creased miRISC cleavage activity of polysome-associated miRNPs 
after treatment at 30°C as compared with control, where the ambi-
ent temperature for translation was not provided (Figure 4C). Higher 
translation of mRNAs with reticulocyte lysate at 30°C was verified by 
adding a firefly luciferase synthetic mRNA in the translation mixture 
under both conditions (unpublished data). This revival of polysomal 
miRNP activity isolated from HDC cells was accompanied by a con-
comitant shift of AGO2 to lighter fractions and was evident when 
the translation mixture after the reaction was resolved on a 30–55% 
sucrose gradient. This shift of AGO2 to lighter fractions indicated 
that the translational boost relieved AGO2 from polysomes and re-
sulted in restoration of RISC activity (Figure 4D). Therefore, in HDC 
cells, low in vivo miRISC activity could be attributed to retention of 
a majority of miRISC with elongating polysomes. This in turn causes 
a relative reduction in accessibility of miRISC to de novo messages 
with a perfect site in HDC cells. We hypothesize that the retention of 
the increased number of miRNPs to bind their targets could make 
the repression partly defective in HDC cells. To test whether limit-
ing substrate concentration could be the reason for identical in 
vivo repression levels observed in LDC and HDC cells, we used a 
higher concentration of reporter for expression in HeLa cells to 
rule out the target RNA unavailability issue and measured both 
repression and mRNA content in HDC and LDC cells. We did not 
detect any major difference in repression level between HDC and 
LDC cells with changing substrate concentration. Of interest, with 
a higher concentration of expression plasmid used for transfection, 
the target RNA level was much higher in HDC than in LDC cells 
(Figure 2, C and D). This observation ruled out limiting substrate 
concentration as a cause of comparable repression of miRNA re-
porter in LDC and HDC cells. Instead it suggested that the higher 
amount of miRNPs present in HDC cells showed impaired RISC-
mediated target cleavage in HDC cells. Consistent with these ar-
guments, we also observed identical in vivo repression levels with 
other miRNA-based reporters with three or more imperfect miRNA 
binding sites in their 3′ UTR by measuring the translation-repres-
sive activity of let-7a and miR-122 miRNPs in HeLa and Huh7 cells 
grown to different cell densities (Figure 2. E and F, and Supple-
mental Figure S3A). The green fluorescent protein (GFP) reporter 
with let-7a sites also showed equal repression in LDC and HDC 
HeLa cells, ruling out any bias with Renilla-based reporters (Sup-
plemental Figure S3B). miRNA repression is usually associated 
with target mRNA degradation in mammalian cells. Note that the 
RL-3xbulge-let-7a RNA exhibited unusual stability of transcripts in 
HDC conditions, analogous to what was obtained with high con-
centration of RL-per-let-7a, and the relative transcript level was 
severalfold higher in HDC cells than in LDC HeLa cells (Figure 2G). 
The mRNAs association with AGO2 was also enhanced in HDC 
cells (Figure 2H). No change in DICER1 association with hemag-
glutinin (HA)-AGO2 was noted. This was accompanied by a reduc-
tion in AGO2-GW182B protein interaction in HDC cells, although 
cellular GW182B level did not change with cell confluency (Figure 
2I, and data not shown). GW182 proteins are known to play an 
important role in repression and degradation of target RNA, and 
therefore reduced AGO2-GW182B interaction in HDC cells corre-
lates with reduced target RNA degradation in HDC cells. These 
observations imply the existence of miRNP-bound mRNAs that are 
translationally silent but are not degraded in HDC cells.
Reduced polysomal disengagement is associated with low 
miRNA turnover and reduced RISC activity in human cells
To resolve this apparent discrepancy between miRNA activity and its 
content in HDC cells and determine the biochemical fraction with 
which “inactive” miRNPs are associated in HDC cells, we analyzed 
whole-cell extracts of HDC and LDC HeLa cells on a 15–55% sucrose 
gradient. Apart from a relatively high 80S peak and comparatively 
lower peaks in the region corresponding to the polysomes, which 
implies reduced protein translation in HDC cells, the 254-nm ab-
sorption profiles of HDC and LDC extracts did not differ significantly 
(Figure 3A). Of interest, however, the gradient profiles of AGO2 pro-
tein were distinct for HDC and LDC samples. For HDC cell extracts, 
AGO2 and miRNA let-7a were both predominantly associated with 
the heavier fractions, whereas in LDC cells, AGO2, was present 
mostly in lighter fractions of the gradient, although some AGO2 was 
also found in the heavier fraction (Figure 3, A and B). Of interest, 
GW182 was found to primarily nonpolysomal in both LDC and HDC 
cells. This also supported the AGO2 immunoprecipitation data, 
which showed a reduction in AGO2-associated GW182B protein in 
HDC cells (Figures 3A and 2I). RCK/p54, another established 
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FIGURE 2: Defective miRNA-mediated repression in HDC human cells. (A) Reporter mRNAs used to measure miRNA 
activity, showing how fold repression was measured (left). In vivo RISC activity of miR-122 in HDC and LDC HeLa cells 
expressing miR-122 and an RL reporter with one perfect miR-122 site (right). (B) RISC cleavage activity of miRISC-122 
isolated from LDC and HDC HeLa cells cotransfected with FH-AGO2 construct and miR-122 expression plasmid. The 
activities were measured and quantified in an in vitro RISC cleavage reaction using 5′-32P-labeled miR-122 target RNA. 
Relative quantification of the RISC activity isolated from LDC and HDC HeLa cells (lanes 1 and 2) was done by 
densitometric analysis. Lane 4, no RISC; in lane 3, a 21-nt-long radiolabeled DNA oligo was used as size marker. The 
RISC-cleaved band is marked by an arrowhead. Western blot for the isolated RISC with anti-HA antibody confirmed 
equal levels of FH-AGO2 protein in each reaction (1 and 2). (C) Invariant repression levels of let-7a miRNA reporter in 
HDC and LDC cells. Cells transfected with low and high concentrations of plasmids encoding the RL reporter with one 
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Therefore slow translation in the presence of CHX resulted in in-
creased retention of miRNA with polysomes, similar to what was 
observed with HDC cells.
Reduced exosomal export of miRNAs causes increased 
miRNA stability in nonproliferative cells
To identify the subcellular location of increased miRNAs in HDC hu-
man cells, we analyzed HDC and LDC cell lysates on an OptiPrep 
density gradient (Augustin et al., 2005) and found that a majority of 
let-7a miRNPs were associated with polysome-enriched/endoplas-
mic reticulum (ER) fractions in HDC cells, whereas in LDC cells, 
miRNA are primarily associated with MVBs, precursor organelles for 
exosome formation (Figure 5, A and B). AGO2-associated miRNAs 
are primarily located with polysomes and ER fractions in HDC cells 
(Figure 5C).
Because MVB association is a prerequisite for exosomal ex-
port of miRNAs (Gibbings et al., 2009), exosome-mediated 
export of miRNA in animal cells may also contribute to the clear-
ance of miRNA from cells. This prompted us to explore how cellular 
confluency could in turn modulate cellular miRNA content by regu-
lating the export process. Using isolated exosomes released by 
HDC and LDC in cell culture medium, we found that exosomal 
miRNA levels were notably lower for both HDC HeLa and MDA-
MB-231 cells for all miRNAs tested without affecting extracellular, 
nonexosomal miRNA content (Figure 6, A and B). This occurs with-
out a major change in exosomal content and character, apart from 
a reduction in exosomal AGO2 level in HDC cells, which was evi-
dent from biochemical or biophysical analysis of the isolated exo-
somes (Figure 6, C–E, and Supplemental Figure S6). Increased 
polysome association of miRNPs in HDC cells therefore could re-
sult in reduced exosomal export and increased miRNA stability in 
HDC HeLa and MDA-MB-231 cells. We earlier observed that reten-
tion of miRNPs with polysomes by application of a low concentra-
tion of CHX resulted in reduced miRNA turnover. To further assess 
whether polysome retention could restrict exosomal export of 
miRNA and account for enhanced cellular miRNA content, we 
measured the exosomal miRNA level upon application of CHX and 
observed that CHX treatment could also suppress exosomal export 
of miRNA in HeLa cells (Figure 6, F and G). From the foregoing 
mRNPs with polysomes restricts its recruitment to new target mR-
NAs, which in turn reduces RISC activity in HDC cells. To explore this 
idea, we incubated the polysomes with reticulocyte lysates for 1 h at 
0 or 30°C before incubating them with a target message for an ad-
ditional 30 min at 0°C. The amount of AGO2-bound mRNA isolated 
under each condition was measured. We noted a higher level of 
target mRNA binding with AGO2 upon release of miRNP from poly-
some postincubation at 30°C (Figure 4E). Therefore, in HDC cells, 
polysomal miRNPs bound to target mRNAs showed reduced re-
pressive activity, possibly due to impairment of subsequent steps 
necessary for clearing the miRNA-bound mRNAs from polysomes.
Translation slowdown down-regulates miRNA turnover 
in human cells
It seems from the previous experiments that retention of miRNPs 
with polysomes resulted in reduced recycling of miRNPs to bind 
new targets and also impairs the subsequent step of target RNA 
degradation by miRNPs. To validate the notion that slow transla-
tion-related retention of miRNPs with polysomes reduces miRNP 
turnover, we measured the AGO2-associated miRNA level in con-
trol and cycloheximide (CHX)-treated cells. Cycloheximide, when 
applied at a low concentration (100 ng/ml), affects the rate of pro-
tein translation in mammalian cells without freezing the elongat-
ing ribosomes (Kong et al., 2008). With CHX treatment, we 
observed an increase of miRNA content (Supplemental Figure 
S5A, left, bottom). As expected, this was also accompanied by an 
increased association of AGO2 with target mRNA (Supplemental 
Figure S5A, left, top). The repression level by increased numbers 
of miRNPs was also curtailed irrespective of the concentration of 
target mRNA expressed (Supplemental Figure S5A, right), whereas 
Western blot analysis showed no major change in levels of pro-
teins associated with miRNA functions upon CHX treatment, ex-
cept a relative decrease of AGO2 level possibly due to the higher 
turnover rate of this protein in mammalian cells (Supplemental 
Figure S5B). Gradient analysis also revealed that CHX at the used 
concentration did not grossly affect the polysome profile of LDC 
HeLa cells (Supplemental Figure S5C). Of interest, the miRNA 
content of the polysomes was significantly enhanced upon 
CHX treatment of LDC HeLa cells (Supplemental Figure S5D). 
perfect let-7a binding site were grown to HDC and LDC, and the normalized repression values were measured in HeLa 
cells. (D) Reduced cleavage of mRNA targets with perfect miRNA site in HDC condition. Real-time quantification of RL 
mRNA level was performed in RNA isolated from RL-per-let-7a–transfected HeLa cells expressing low and high 
concentrations of reporter and grown to HDC and LDC conditions. The 18S rRNA normalized relative levels of RL 
mRNA for individual samples are plotted. Values in the LDC state are set to 1. (E) Relative repression level of two let-7a 
reporters with multiple imperfect let-7a binding sites in HeLa cells from HDC and LDC conditions. RL-HMGA2 has a 3′ 
UTR of let-7a target gene HMGA2. RL-HMGA2-Mut with mutated let-7a sites served as control. For RL-3xbulge-let-7a, 
RL-Con was used as control. (F) Relative fold repression of RL reporter with three imperfect let-7a binding sites in cells in 
which an increasing amount of reporter-encoding plasmid was used for transfection of HeLa cells. (G) Real-time PCR 
detection of RL mRNA in RL-3xbulge-let-7a– or RL-Con–transfected HeLa cells under similar experimental conditions as 
in E. (H) Association of target mRNA with AGO2 in HDC and LDC HeLa cells expressing RL-3xbulge-let-7a. N-HA-AGO2 
was immunoprecipitated with anti-HA antibody from cells coexpressing it along with RL reporter. Control 
immunoprecipitation reaction was performed with anti-GFP antibody. Western blot analysis of the IPed AGO2 was 
performed, and associated DICER1 was detected (top). RNA extracted from the lysates was used to determine the 
amount of RL mRNA associated with AGO2 by PCR (top) and also quantified by real-time PCR (bottom). (I) Association 
of GW182B with AGO2 in HDC and LDC cells. Cells expressing FH-AGO2 were grown to HDC and LDC states, 
HA-AGO2 was immunoprecipitated with anti-FLAG antibody, and associated GW182B was detected. All experiments 
were performed a minimum of three times. Here Low and High refer, respectively, to 25 and 100 ng of plasmids used 
for transfection of cells present per well of a six-well plate. In F, +, ++, and +++ represent respectively 25, 100, and 
500 ng of plasmid transfected per well of a six-well plate. For all relevant panels, ns, nonsignificant, *p < 0.05, 
**p < 0.01, and ***p < 0.0001. The p values were determined by paired t test, and results depict mean values from at 
least three experiments.
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levels only, without much effect on mRNA level of miRNA-targeted 
messages, and this too is a controversial aspect of miRNA re-
search. In LDC cells, miRNAs are predominantly associated with 
lighter fractions of a sucrose density gradient, whereas miRNPs 
are primarily present with heavier polysomes in HDC cells. The 
GW182-CCR4-NOT1 complex recruits the ATPase RCK/p54 to 
AGO2 and induces translation repression and target RNA degra-
dation in animal cells. Therefore relative loss of RCK/p54 from the 
polysomal fraction in HDC cells could be due to reduced interac-
tion between AGO2 and GW182 (Chen et al., 2014; Mathys et al., 
2014; Rouya et al., 2014). Ineffectiveness of polysome-attached 
miRNPs to induce degradation of target genes in HDC cells sup-
ports the model of miRNA-mediated repression at the initiation 
step followed by target RNA deadenylation and degradation 
(Djuranovic et al., 2012). Our data support a mechanism by which 
mRNAs attached to polysomes could be targeted by miRNPs but 
are not repressed or degraded before the elongating ribosomes 
complete their individual ongoing round of translation. Deploy-
ment of ribosomes from target mRNA is found to be essential for 
recycling or exosomal export of miRNAs. In HDC cells, where the 
translation rate is compromised (Azar et al., 2010), the polysome 
association time of miRNPs is prolonged and the miRNPs remain 
attached with translating mRNAs for a relatively longer time. This 
can explain why the increased numbers of miRNPs become less 
available for de novo target repression in HDC cells or in cells with 
a slow rate of translation. It suggests a processive mechanism of 
experiments, we noted a good correlation of low miRNA export 
and high cellular miRNA content in HDC cells. We applied GW4869 
as an inhibitor of SMPD2, a protein important for exosomal export 
of miRNA in animal cells (Kosaka et al., 2010). By preventing sphin-
gomyelin synthesis, GW4869 restricts exosomal export of miRNA 
and enhances cellular miRNA content in LDC MDA-MB-231 cells. 
Of interest, GW4869-mediated increase of miRNA was moderate 
in HDC cells, arguing in favor of exosomal export of miRNA as a 
key mechanism of miRNA turnover that is already restricted in HDC 
cells. As a consequence, these cells are less responsive to GW4869 
treatment and do not show a major increased miRNA level upon 
drug treatment (Figure 6H).
DISCUSSION
With increasing cell density in monolayer culture, we documented 
an increase in mature miRNA levels in human cells due to stabiliza-
tion of its mature form. According to Hwang et al. (2009), cell–cell 
contact increases miRNA production and activity in mammalian 
cells by increasing Drosha-DGCR8–mediated processing of pri-
miRNAs and its incorporation to AGO proteins. This may be an al-
ternative mechanism of increased miRNP production in HDC cells 
for specific miRNAs. However, siRNA and miRNA stability experi-
ments confirmed that increased levels of these small RNAs in HDC 
cells are primarily caused by their higher stability in HDC cells.
miRNP association with polysomes has long baffled miRNA 
researchers. For certain targets, repression is evident at protein 
FIGURE 3: miRNPs in HDC human cells are retained with polysomes. (A, B) HDC and LDC HeLa cell extracts were 
analyzed on a 15–55% sucrose density gradient and collected in 10 different fractions while simultaneous absorption at 
254 nm was monitored and plotted. The proteins isolated from individual fractions were Western blotted to obtain the 
distribution profile of AGO2, GW182, and RCK/p54 protein (A). Isolated RNAs from each fraction were analyzed by 
Northern blot for let-7a (A) and subsequently quantified as a percentage of total signals (B, left). FH-AGO2 
immunoprecipitated from nonpolysomal fractions 1 and 2 and polysomal fractions 5–7 from transfected HeLa cells in a 
parallel experiment was assayed for RISC cleavage activity. (B) Right, representative graph of efficiency of RISC cleavage 
of the denoted fractions. (C) Polysomal miRNA content increase in HDC HeLa cells. RNA isolated from polysomes of 
LDC and HDC HeLa cells cotransfected with FH-AGO2 and miR-122 expression plasmid was quantified for endogenous 
miR-16, miR-21, let-7a, and exogenous miR-122 levels. (D) Association of let-7a reporter with different fractions of 
polysome gradient of HDC and LDC HeLa cells expressing RL-3xbulge-let-7a reporter mRNA. For all relevant panels, ns, 
nonsignificant, *p < 0.05, **p < 0.01, and ***p < 0.0001. The p values were determined by paired t test, and results 
depict mean values from at least three experiments.
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Evidently, slow translation arrests miRNPs on polysomes but it is 
not clear why the miRNP retention with polysomes should restrict its 
MVB targeting. miRNA homeostasis is controlled by several factors 
that contribute to buffering cellular miRNA level and stability in ani-
mal cells. Although there are indications that RISC interacts with 
MVBs, very little is known as to why and under what circumstances 
this occurs. Exosomal export and delivery of several RNAs and pro-
teins have received much attention, and they have been suggested 
to mediate changes in several physiological pathways often impli-
cated in the regulation of cell growth. We speculate that compart-
mentalization of miRNAs to polysomes, thus affecting extracellular 
export, may have a key role in negotiating progrowth and anti-
growth signals in cells in various environments.
MATERIALS AND METHODS
Cell culture and transfection
Human HeLa, MDA-MB-231, and Huh7 cells were all grown in DMEM 
supplemented with 2 mM l-glutamine and 10% heat-inactivated 
miRNA-mediated translation repression in which miRNPs, already 
engaged with target mRNAs, have to finish their repressive job 
before they can target another message. Thus arresting miRNPs 
with polysomal mRNAs will in turn increase stability of both 
miRNAs and target mRNAs with no change in the AGO2 protein 
level (Figure 7).
Our study showed that cell–cell contact has a strong effect on 
miRNA-mediated gene regulation pathways and plays a greater 
role than previously believed. It also satisfactorily answers and 
supports various proposed mechanisms of the mode of action of 
miRNAs.
Stalder et al. (2013) showed rough ER to be the site where 
miRNPs are enriched and interact with their targets. From this study, 
it seems that the majority of AGO2 is present with MVBs and/or 
polysomal fractions. How loaded miRNPs are transferred to MVB 
fractions is an unresolved issue. Regulated interorganellar transport 
to control miRNA activity in mammalian cells is a possibility that 
needs to be studied further.
FIGURE 4: miRNP retention in polysomal pool precludes its RISC activity. (A) Assay to measure RISC cleavage activity of 
polysomal miRISC-122 isolated from LDC and HDC HeLa cells cotransfected with FLAG-HA-AGO2 and miR-122 
expression plasmid. Normalization of RISC activity was done against the HA-AGO2 detected by Western blot analysis. 
(B) Relative specific activity of polysomal miRISC-122 isolated from HDC and LDC states with respect to AGO2 protein 
levels (left axis) or AGO2-associated miR-122 content (right axis). (C) In vitro translation activates polysomal miRISC. 
Polysomes isolated from HDC HeLa cells transfected with miR-122 expression plasmid was subjected to in vitro 
translation in rabbit reticulocyte lysates for 1 h at 30 and 0°C (control) before measuring the RISC activity at 30°C. Left, 
autoradiogram showing the end product of the reaction analyzed on a denaturing PAGE. Arrowhead marks the cleaved 
RNA bands. Right, relative RISC activity. (D) Distribution of FH-AGO2 on a 30–55% sucrose gradient after isolated 
polysomes from HDC HeLa cells were incubated with rabbit reticulocyte lysates at 30°C for 1 h. FH-AGO2 distribution 
at 0°C served as control. Top, FH-AGO2 detected by Western blot with anti-HA antibody. Bottom, quantification of the 
AGO2 levels in different fractions done by measuring the band intensity. (E) Binding of AGO2 to new target RNA is 
reciprocal to its association with polysomes. Top, scheme of the experiment. Bottom, relative amount of RL-3xbulge-
miR-122 mRNA bound to FH-AGO2 after the polysomal FH-AGO2 was subjected to translation reaction at 37 or 0°C. 
ns, nonsignificant, *p < 0.05, **p < 0.01, and ***p < 0.0001. The p values were determined by paired t test. All 
experiments were performed a minimum of three times.
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24 h posttransfection. Pre-miR-122 was 
cloned into pTRE-Tight-BI Vector from Clon-
tech (Mountain View, CA) into NheI and NotI 
sites. Cells cotransfected with Tet on ad-
vanced plasmid and expressing FH-AGO2 
was retransfected with the miR-122–express-
ing cassette, and miR-122 expression was 
induced with doxycycline (300 ng/ml) for 10 h 
during cell lysis and immunoprecipitation.
Luciferase assay and Northern 
and Western blots
RL and FL activities were measured using 
a Dual-Luciferase Assay Kit (Promega, 
Madison, WI) following the supplier’s proto-
col on a VICTOR X3 Plate Reader with injec-
tors (PerkinElmer, Waltham, MA). FL-nor-
malized RL expression levels for reporter 
and control were used to calculate fold re-
pression as the ratio of normalized control 
to reporter RL values. To avoid discrepancy 
in transfection efficiencies and avoid differ-
ential dilution of DNA cue to variable cell 
number, all transfections were performed in 
a single plate before splitting equal num-
bers of cells into plates of variable diameter 
to achieve LDC and HDC conditions.
Northern blotting of total cellular RNA 
(5–15 μg) was performed as described by 
Pillai et al., (2005). For detection, 32P-
labeled 22-nt antisense DNA probes spe-
cific for respective miRNAs or siRL or U6 
snRNA were used. Phosphorimaging of 
the blots was performed in the Cyclone 
Plus Storage Phosphor System (Perkin-
Elmer), and Optiquant software (Perkin-
Elmer) was used for quantification.
Western analyses of different miRNP 
components (AGO2, RCK/p54, and XRN1) 
were performed as described previously. 
Detailed list of antibodies used are given in 
Supplemental Table S3. Imaging of all West-
ern blots was performed using an UVP Bio-
Imager 600 system equipped with Vision-
Works Life Science software, version 6.80 
(UVP, Cambridge, UK).
Polysome analysis
For polysome analysis, ∼2 × 107 HeLa cells grown to the desired 
level of confluency (LDC and HDC) were lysed in a buffer con-
taining 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid (HEPES), pH 8.0, 25 mM KCl, 5 mM MgCl2, 1 mM dithiothre-
itol (DTT), 5 mM vanadyl ribonucleoside complex, 1% Triton 
X-100, 1% sodium deoxycholate, and 1× EDTA-free protease in-
hibitor cocktail (Roche) supplemented with CHX at 100 μg/ml 
(Calbiochem). Gradient analysis was performed as described 
previously (Pillai et al., 2005; Bhattacharyya et al., 2006). The 
absorbance profile was obtained by using an ISCO UA-6 absor-
bance monitor, and fractions were collected on a ISCO gradient 
fractionator. RNA and proteins from the individual fractions 
were isolated and analyzed following published procedures 
(Bhattacharyya et al., 2006).
fetal calf serum (FCS). For transcription and translation inhibition 
experiments, α-Am (10 μg/ml) and CHX (100 ng/ml), both from 
Calbiochem (Billerica, MA), were dissolved in dimethyl sulfoxide 
(DMSO) and added to cells as described (Bhattacharyya et al., 2006). 
DMSO was added to controls (final concentration of 0.1%). For all 
experiments, cells were grown to 25–40% confluency (LDC) or were 
fully (100%) confluent (HDC) unless specified otherwise. Transfections 
were performed using Lipofectamine 2000 (Invitrogen, Bangalore, 
India) following the manufacturer’s protocol. For miRNA repression 
assays, 25–500 ng of Renilla luciferase (RL) reporter plasmids with 500 
ng of firefly luciferase (FL) plasmid were cotransfected per well of a 
six-well format (10-cm2 area), followed by splitting the cells to the 
desired HDC or LDC conditions and lysing them subsequently after at 
least 24 h of growth. siRNAs and miRVana mimics were transfected at 
50 nM concentration. All transfections were followed by a cell split at 
FIGURE 5: Reduced MVB localization and exosomal export of miRNA in HDC human cells. 
(A) Subcellular miRNA distribution in HeLa cells grown to LDC and HDC conditions. Cell 
homogenates from HDC and LDC cells were analyzed on a 3–30% OptiPrep gradient to 
separate the subcellular organelles, and Northern blot analysis for let-7a was performed with 
each fraction; relative distributions are plotted. AGO2 distribution was detected by Western 
blotting. (B) Subcellular distributions of different marker proteins and RNA to detect MVB, ER, 
and polysomal fractions in HDC and LDC cell extracts are shown to confirm effective 
fractionation. Positions of the 26S and 18S rRNAs are marked by arrows. Relative position of 
each organelle is shown in the top for both A and B. (C) Fold change in miRNA association of 
FH-AGO2 present in different OptiPrep fractions in HDC cells. FH-AGO2–expressing HeLa cells 
were grown to HDC and LDC states before lysis and separation of fractions on a gradient as 
described. Individual fractions were pooled, and FH-AGO2 was immunoprecipitated. From the 
IPed FH-AGO2, each fraction was used to measure associated let-7a by real time PCR. Left, 
Western blot of IPed FH-AGO2. **p < 0.01. The p value was determined by paired t test. 
Results depict mean values from at least three experiments.
Volume 26 March 15, 2015 Polysome association inactivates miRNAs | 1081 
Affinity purification of miRISC and in 
vitro RISC cleavage assay
FLAG-HA-AGO2 (FH-AGO2) expression 
plasmid was cotransfected in HeLa cells 
with plasmid expressing pre-miR122. Cell 
lysis and miRISC purification was done fol-
lowing published protocols (Kundu et al., 
2012).
Affinity-purified miRISC-122 was as-
sayed for target RNA cleavage using a 
36-nt RNA, 5′AAAUUCAAACACCAUU-
GUCACACUCCACCAGAUUAA3′, bearing 
the sequence complementary to mature 
miR-122 (underlined). Target RNA cleavage 
assays were carried out in a total volume of 
30 μl with 10 fmol of 5′ 32P-labeled RNA 
and protein-equivalent amounts of RISC at 
30°C for 30 min, followed by RNA isolation, 
and cleaved products were analyzed on a 
12% denaturing 8 M urea-PAGE before 
autoradiography.
In vitro translation with rabbit 
reticulocyte lysate
Total polysomes separated on a 30% su-
crose cushion were resuspended in poly-
some buffer lacking one of 1% Triton 
X-100, 1% sodium deoxycholate, or CHX. 
Isolated polysomes corresponding to 
4 × 106 HDC HeLa cells were used for in 
vitro translation as per manufacturer’s 
FIGURE 6: Exosomal export of miRNA is curtailed in cells grown to high density (A) Levels of let-
7a, miR-16 and miR-24 miRNAs in FACS sorted identical number of exosomes released by HeLa 
and MDA-MB-231 cells grown to LDC or HDC cells (mean+/– SEM, n = minimum 3). (B) Amount 
of miRNA present in cell culture supernatant of HDC and LDC cells after removal of exosomes. 
(C) miRNA and AGO2 present in cell culture supernatant of HeLa cells is membrane protected. 
Conditioned medium from LDC state HeLa cells were treated with Triton X-100 for 15 min 
before they were used for exosome isolation. 
The estimation of miRNA was done by real 
time quantification and Ct values are plotted. 
AGO2 levels were detected by Western blot 
analysis. (D) Levels of CD63 exosomal marker 
proteins, present in cell equivalent amount of 
exosomes isolated from HDC and LDC state 
cells. (E) Relative levels of exosomal AGO2, 
HRS and HSP90 in exosomes isolated from 
LDC and HDC MDA-MB-231 cells. Absence 
of Dicer and β-Actin was used to rule out any 
cellular contamination in isolated exosomes. 
(F, G) Effect of CHX treatment on AGO2 and 
miRNA export via exosomes. Western blot 
for AGO2 in exosomes from DMSO or CHX 
treated LDC HeLa cells. CD63 levels were 
used to negate the variance in the release of 
exosomes as a consequence of CHX 
treatment (F). miRNA levels were quantified 
by real-time based quantification and Ct 
values were plotted (G). (H) Effect of GW4869 
treatment on miRNA content of HDC and 
LDC state. Real time PCR based estimation of 
miR-122 was done with RNA from miR-122 
expressing HeLa cells grown to either LDC or 
HDC state in the presence or absence of 
GW4869. ns, nonsignificant, *p < 0.05, 
**p < 0.01, ***p < 0.0001. p values were 
determined by paired t test. Results depict 
mean values from at least three experiments. 
CM, conditioned medium.
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Streptavidin magnetic beads coated with 
biotinylated capture antibodies were used 
as per manufacturer’s protocol 
(EXOFLOW150A-1; System Biosciences). 
All of the precipitated MDA-MB-231 exo-
somes were added to the beads and kept 
at 4°C overnight for affinity interaction. 
Beads containing pulled-down exosomes 
were then washed (as per manufacturer’s 
protocol) and stained with the Exo-FITC 
universal exosome stain provided in the 
kit. Stained exosomes were then visual-
ized on a BD LSR Fortessa FACS machine 
(BD Biosciences). An identical number of 
affinity-purified exosomes was eluted from 
the beads (as per manufacturer’s protocol) 
and proteins and RNA isolated for subse-
quent analysis. Biophysical analysis of 
exosomes from MDA-MB-231 cells was 
carried out as described (Basu and Bhat-
tacharyya, 2014).
Fractionation and separation of 
endosomes and ER on OptiPrep 
gradients
OptiPrep (Sigma-Aldrich, St. Louis, MO) 
was used to prepare a 3–30% continuous 
gradient in a buffer containing 78 mM 
KCl, 4 mM MgCl2, 8.4 mM CaCl2, 10 mM 
ethylene glycol tetraacetic acid (EGTA), 
and 50 mM HEPES-NaOH (pH 7.0) for 
separation of subcellular organelles as de-
scribed previously, with minor modifica-
tions (Gibbings et al., 2009). Cells were 
trypsinized, washed, and homogenized 
with a Dounce homogenizer in a buffer 
containing 0.25 M sucrose, 78 mM KCl, 4 
mM MgCl2, 8.4 mM CaCl2, 10 mM EGTA, 
and 50 mM HEPES-NAOH, pH 7.0, sup-
plemented with 100 μg/ml CHX, 5 mM 
vanadyl ribonucleoside complex (Sigma-
Aldrich), 0.5 mM DTT, and 1× protease 
inhibitor. The lysate was clarified by cen-
trifugation at 1000 × g for 5 min and lay-
ered on top of the prepared gradient. The 
tubes were centrifuged for separation of 
gradient using established protocols, and 
10 fractions were collected for further analysis or pooled for 
immunoprecipitation studies.
Postimaging analysis and others
All Western blot and Northern blot images were processed with 
Photoshop CS4 (Adobe) for all linear adjustments and cropping. 
Image cropping was done using Photoshop CS4. Statistical analy-
sis of data was done by performing paired/unpaired, nonparamet-
ric, two-tailed t tests with a confidence interval of 95%, and four 
significant digits were considered in all cases. ns, nonsignificant, 
*p < 0.01, **p < 0.001, and ***p < 0.0001 in all cases. Additional 
information on plasmids, siRNAs, oligos, and antibodies used is 
provided in Supplemental Tables S1 and S2. Additional informa-
tion on methodologies is available in the Supplemental Materials 
and Methods.
protocol (Promega). Translation was carried out at 30°C for 
1 h; control sets were incubated on ice for the same duration. 
The reaction was terminated with the addition of 100 μg/ml 
CHX, and RISC cleavage assay of the total reaction mixture 
was performed as described previously. To check the distri-
bution of AGO2 in the polysomes upon translation, instead of 
performing the RISC cleavage assay, the whole translation 
mixture was loaded on a 30–55% sucrose cushion and cen-
trifuged for 2 h at 36,000 rpm in a SW60 rotor in an 
ultracentrifuge.
Exosome isolation and characterization
Exosomes were isolated based on published protocols (Thery 
et al., 2006) in a two-step process using a sucrose cushion in an 
ultracentrifuge. For affinity-based purification of exosomes, 
FIGURE 7: Polysome retention precludes exosomal export of miRNAs in growth retarded 
human cells and modulate cellular miRNA level and activity. The polysomal miRNPs are found to 
be functionally inactive in processing of repressed mRNAs in HDC human cells. Our results 
support existence of miRNPs in mammalian cells in either active or inactive pools that is 
primarily determined by their polysome attachment. Reduced protein translation rate in HDC 
cells increases polysome association and alters subcellular distribution of miRNPs and hence 
extracellular secretion as well.
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